News

Q&A with Roy Herbst, MD, PhD, medical oncologist, in recognition of Lung Cancer Awareness Month.

Researchers from Yale University, and the University of Texas Southwestern Medical Center have been awarded a $12.4 million, five-year grant from the National Institute on Aging of the NIH to deploy their unique research models and expertise in a coordinated fashion to develop a novel course of gerontological research.

The Yale Translational Research Imaging Center (Y-TRIC) is recruiting T32 post-doctoral fellows.

The annual Yale Faculty Innovation Awards are an opportunity to recognize the significant contributions of faculty investigators who launch startups in order to address global challenges.

The traits of a particular species are not merely the result of its genes but also the proteins for which those genes code. Understanding the differences among species’ proteomes—or all of the proteins that can be expressed—is, therefore, as important as understanding differences among genomes.

A new study from Yale Cancer Center scientists has identified the chromatin regulator WDR5 as a possible new drug target in triple negative breast cancer.

Yale researchers have now uncovered a key part of the process that generates an additional protective layer of the cell wall of bacteria, a finding that may help reveal vulnerabilities that could be targeted by new antibiotics.

The Diversity Enhancement Program in Oncology program offers an eight-week rotation for two underrepresented in medicine (URiM) students or residents, and is designed to provide exposure to hematology/medical oncology as a career, provide faculty-mentored clinical experience in oncology as well as with a corresponding clinical or translational research project. Students also receive co-mentorship from current Medical Oncology-Hematology T32 fellows.